The Advances in Chronic Hepatitis C: Management and Treatment program is a comprehensive, independent review of the 66th American Association for the Study of Liver Diseases Annual Meeting (AASLD 2015). This program consists of six components: (1) CME Internet Symposium: AASLD 2015 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) CME Internet Symposium: European Perspective on AASLD 2015: a 1-hour Internet symposium featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in the EU; (3) CME Internet Symposium: Brazilian Perspective on AASLD 2015: a 1-hour Internet symposium featuring Brazil-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in Brazil; (4) Comprehensive Expert Review and Discussion of Key Presentations: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium (5) Rapid-Fire Independent Review of AASLD 2015: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (6) From Conference To Clinic: Reviewing And Applying Data From AASLD 2015: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.
The CME Internet Symposium: Brazilian Perspective on AASLD 2015 will provide a Brazilian focused review and discussion of the key studies on chronic hepatitis C presented at AASLD 2015. The expected result is that Brazil-based participants will not only gain an increased understanding of key data presented at AASLD 2015, they will also be better prepared to address their HCV patients’ health needs and provide optimal care, which should improve treatment and adherence, increase individualized care, reduce adverse effects and drug-drug interactions, and improve quality of life for people with chronic hepatitis C throughout Brazil.
All online components of the program can be accessed at www.viraled.com.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at AASLD 2015 and it is not sanctioned by the organizers of AASLD 2015.
Mário G. Pessoa, MD, PhD Assistant Professor Division of Gastroenterology and Hepatology University of São Paulo School of Medicine São Paulo, Brazil |
Mauro Schechter, MD, PhD Professor of Infectious Diseases Department of Preventive Medicine Federal University of Rio de Janeiro, Brazil Rio de Janeiro, Brazil |
Hugo Cheinquer, MD, PhD Associate Professor of Gastroenterology and Hepatology Universidade Federal do Rio Grande do Sul School of Medicine Porto Alegre, RS, Brazil |
After completing this activity, the participant should be better able to:
Release Date: December 15, 2015
Expiration Date: December 15, 2016
Estimated time to complete the AASLD 2015 Brazil Internet Symposium: 1 hour, 15 minutes
Media: Internet
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals in Brazil involved in the treatment and management of patients with HCV infection.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to provideing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commerical interest.
Hugo Cheinquer, MD, PhD
Mario Pessoa, MD
Mauro Schechter, MD
The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Judi Smelker-Mitchek, RN, BSN; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Shultz, RN, MSN, CCMEP and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.
There are no fees for participating and receiving CME credit for this activity. During the period, December 15, 2015 through December 15, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10853. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.